A Prospective Multicenter Observational Study for Dacogen Long-Term Treatment in Patients With Myelodysplastic Syndrome.
Phase of Trial: Phase IV
Latest Information Update: 12 Dec 2017
At a glance
- Drugs Decitabine (Primary)
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- Acronyms DRAMA
- Sponsors Janssen
- 12 Dec 2017 Results (n=130) of two observational studies (DIVA and DRAMA) assessing overall survival, presented at the 59th Annual Meeting and Exposition of the American Society of Hematology.
- 16 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Feb 2014 Planned End Date changed from 1 Dec 2015 to 1 Apr 2014 as reported by ClinicalTrials.gov.